REFILE-UPDATE 2-U.S. FDA approves AbbVie hepatitis C drug, costs $83,319 for 12 weeks December 22, 2014 by Harry Joiner - Add Comment EmailPrint(Corrects typographical error in first paragraph to Sovaldi instead of Solvadi) Source: Financials